Background illustration for clinical trials search

Paid Clinical Trials Pittsburgh

Discover 1,166 paid clinical trials in Pittsburgh, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer

for
Oropharynx Cancer
Location: Pittsburgh PA
Sponsor: Heath Skinner

Sex: All

Age: 18+

Code: NCT05388773

Phase 2, Recruiting

Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)

for
Gastroesophageal Junction, Gastroesophageal Adenocarcinoma,
Location: Pittsburgh PA, East Syracuse NY, Grand Rapids MI,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06469944

Phase 1, Phase 2, Recruiting

Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma

for
Peritoneal Malignant Mesothelioma
Location: Pittsburgh PA, Columbus OH, Danville IL, Chicago IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05001880

Phase 2, Recruiting

Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System

for
Locally Recurrent Skin Squamous Cell Carcinoma,
Location: Pittsburgh PA, Beachwood OH, Cleveland OH, Avon OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07042295

Phase 2, Recruiting

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

for
Prostatic Neoplasms, Castration-Resistant
Location: Pittsburgh PA, Hershey PA, Fairfax VA, Towson MD,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07225946

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F)

for
Oesophageal Squamous Cell Carcinoma
Location: Pittsburgh PA
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07405151

Phase 1, Phase 2, Recruiting

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

for
Metastatic Malignant Solid Neoplasm,
Location: Pittsburgh PA, Columbus OH, Lexington KY, Chicago IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05372614

Phase 1, Recruiting

Investigating Real-Time Immunotherapy Symptoms Study

for
Cancer, Melanoma (Skin Cancer), Immunotherapy
Location: Pittsburgh PA
Sponsor: University of Pittsburgh

Sex: All

Age: 18+

Code: NCT07280715

Recruiting

Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies

for
Acute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia (AML),
Location: Pittsburgh PA
Sponsor: Sawa Ito, MD

Sex: All

Age: 18+

Code: NCT07565220

Phase 1, Recruiting

Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma

for
Recurrent Plasmablastic Lymphoma,
Location: Pittsburgh PA, Columbus OH, Deerfield Beach FL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07332507

Phase 1, Recruiting

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

for
Astrocytoma, IDH-Mutant, Grade 2,
Location: Pittsburgh PA, Columbus OH, Richmond VA, Lexington KY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06860594

Phase 1, Recruiting

A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

for
Chronic Graft-versus-host-disease
Location: Pittsburgh PA, Columbus OH, Detroit MI, Chicago IL,
Sponsor: Syndax Pharmaceuticals

Sex: All

Age: 2+

Code: NCT04710576

Phase 2, Recruiting

Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Location: Pittsburgh PA, Cincinnati OH, Philadelphia PA,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT07493512

Phase 1, Recruiting

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

for
Recurrent Glioblastoma, IDH-Wildtype,
Location: Pittsburgh PA, Columbus OH, Cincinnati OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05432804

Phase 1, Phase 2, Recruiting

A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC

for
ALK-positive NSCLC, ALK-Positive Lung Cancer,
Location: Pittsburgh PA, Fairfax VA, Maumee OH, Cincinnati OH,
Sponsor: TRIANA Biomedicines, Inc.

Sex: All

Age: 18+

Code: NCT07491497

Phase 1, Phase 2, Recruiting

Window of Opportunity in Preserving Laryngeal Function Trial

for
Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M),
Location: Pittsburgh PA
Sponsor: Matthew Spector

Sex: All

Age: 18+

Code: NCT07423078

Phase 2, Recruiting

A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.

for
Colorectal Cancer
Location: Pittsburgh PA, Durham NC, Florida City FL,
Sponsor: Kahr Bio Australia Pty Ltd

Sex: All

Age: 18+

Code: NCT07235293

Phase 2, Recruiting

Distance-Based Exercise to Preserve Function and Prevent Disability

for
Localized Malignant Solid Neoplasm, Anal Cancer,
Location: Pittsburgh PA, Butler PA, Indiana PA, New Castle PA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT07059884

Recruiting

Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma

for
Sinonasal Squamous Cell Carcinoma,
Location: Pittsburgh PA, Charlottesville VA, Lexington KY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07281417

Phase 2, Recruiting

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

for
Chronic Lymphocytic Leukemia
Location: Pittsburgh PA, Hamilton, Durham NC, New York NY,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07277231

Phase 3, Recruiting